Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02791542 · ClinicalTrials.gov registry record

Sorting and Expression Profiling of Airway Cells From Humans (The SEARCH Study)

A clinical trial, sponsored by University of California, San Francisco.

Completed
Registry status
32
Enrollment target

NCT02791542 is a clinical trial that has completed, run by University of California, San Francisco. The registered enrollment target is 32 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02791542 has completed, sponsored by University of California, San Francisco.

COMPLETED
Registry status
32 participants
Enrollment target

Study Summary

This will be a single site, mechanistic study of asthmatic subjects and healthy, non-asthmatic controls involving a baseline characterization visit and a research bronchoscopy visit. We will identify differences in airway epithelial epigenetic enhancer signatures in asthma, by analyzing freshly isolated airway epithelial cells from healthy controls and from well-characterized subjects with asthma.

Trial Details

FieldValue
Enrollment Target 32 participants
Start Date 2017-01
Est. Completion 2023-03

What the Registry Record Tells You About NCT02791542

The ClinicalTrials.gov registry entry for NCT02791542 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT02791542 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02791542 about?

NCT02791542 is a clinical study titled "Sorting and Expression Profiling of Airway Cells From Humans (The SEARCH Study)". This will be a single site, mechanistic study of asthmatic subjects and healthy, non-asthmatic controls involving a baseline characterization visit and a research bronchoscopy visit. We will identify differences in airway epithelial epigenetic enhancer signatures in asthma, by analyzing freshly isol...

What is the current status of trial NCT02791542?

This trial is currently completed. The enrollment target is 32 participants. The study started on 2017-01. Estimated completion is 2023-03.

Who is sponsoring clinical trial NCT02791542?

This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.